ArticleBritish journal of cancer2020

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Eric Lévesque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.